Intravenous Thyroxine for Heart-Eligible Organ Donors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This randomized controlled trial will evaluate whether intravenous thyroxine infusion given to brain-dead organ donors who are eligible to donate hearts for 12 hours will result in more hearts transplanted than saline placebo
Epistemonikos ID: 215e7ca3a057624cfaae0df7a04c18201d685dc7
First added on: May 07, 2024